PCBP1/2 and TDP43 Function as NAT10 Adaptors to Mediate mRNA ac 4 C Formation in Mammalian Cells

Massive numbers of modified bases in mRNAs sculpt the epitranscriptome and play vital roles in RNA metabolism. The only known acetylated RNA modification, N-4-acetylcytidine (ac C), is highly conserved across cell types and among species. Although the GCN5-related acetyltransferase 10 (NAT10) functi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced science 2024-12, Vol.11 (47), p.e2400133
Hauptverfasser: Jiang, Zhi-Yan, Wu, Yu-Ke, Deng, Zuo-Qi, Chen, Lu, Zhu, Yi-Min, Yu, Yuan-Song, Wu, Hong-Bo, Fan, Heng-Yu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Massive numbers of modified bases in mRNAs sculpt the epitranscriptome and play vital roles in RNA metabolism. The only known acetylated RNA modification, N-4-acetylcytidine (ac C), is highly conserved across cell types and among species. Although the GCN5-related acetyltransferase 10 (NAT10) functions as an ac C writer, the mechanism underlying the acetylation process is largely unknown. In this study, the NAT10/PCBP/TDP43 complex mediated mRNA ac C formation in mammalian cells is identified. RNA-binding proteins (RBPs) are identified, affiliated with two different families, poly(rC)-binding protein 1/2 (PCBP1/2) and TAR DNA binding protein 43 (TDP43), as NAT10 adaptors for mRNA tethering and substrate selection. Knockdown of the adaptors resulted in decreased mRNA acetylation abundance in HEK293T cells and ablated cytidine-rich ac C motifs. The adaptors also affect the ac C sites by recruiting NAT10 to their binding sequences. The presence of the NAT10/PCBP/TDP43 complex in mouse testes highlights its potential physiological functions in vivo. These findings reveal the composition of the mRNA ac C writer complex in mammalian cells and expand the knowledge of mRNA acetylation and ac C site preferences.
ISSN:2198-3844
2198-3844
DOI:10.1002/advs.202400133